These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 572656)

  • 1. Killer phenomenon in pathogenic yeast.
    Kandel JS; Stern TA
    Antimicrob Agents Chemother; 1979 Apr; 15(4):568-71. PubMed ID: 572656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High incidence of sensitivity to yeast killer toxins among Candida and Torulopsis isolates of human origin.
    Middelbeek EJ; Hermans JM; Stumm C; Muytjens HL
    Antimicrob Agents Chemother; 1980 Mar; 17(3):350-4. PubMed ID: 7191690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strain differentiation of pathogenic yeasts by the killer system.
    Morace G; Archibusacci C; Sestito M; Polonelli L
    Mycopathologia; 1984 Feb; 84(2-3):81-5. PubMed ID: 6371541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Killer system: a simple method for differentiating Candida albicans strains.
    Polonelli L; Archibusacci C; Sestito M; Morace G
    J Clin Microbiol; 1983 May; 17(5):774-80. PubMed ID: 6345575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of killer yeasts in isolates of clinical origin.
    Robledo-Leal E; Villarreal-Treviño L; González GM
    Trop Biomed; 2012 Jun; 29(2):297-300. PubMed ID: 22735852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the killer character in different yeasts and its classification.
    Young TW; Yagiu M
    Antonie Van Leeuwenhoek; 1978; 44(1):59-77. PubMed ID: 655699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large-scale screening of selected Candida maltosa, Debaryomyces hansenii and Pichia anomala killer toxin activity against pathogenic yeasts.
    Buzzini P; Martini A
    Med Mycol; 2001 Dec; 39(6):479-82. PubMed ID: 11798052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The occurrence of killer characters in yeasts.
    Rosini G
    Can J Microbiol; 1983 Oct; 29(10):1462-4. PubMed ID: 6661706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening and Identification of Yeasts Antagonistic to Pathogenic Fungi Show a Narrow Optimal pH Range for Antagonistic Activity.
    Chen PH; Chou JY
    Pol J Microbiol; 2017 Mar; 66(1):101-106. PubMed ID: 29359688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between killer yeasts and pathogenic fungi.
    Walker GM; McLeod AH; Hodgson VJ
    FEMS Microbiol Lett; 1995 Apr; 127(3):213-22. PubMed ID: 7758935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ecological role of killer yeasts in natural communities of yeasts.
    Starmer WT; Ganter PF; Aberdeen V; Lachance MA; Phaff HJ
    Can J Microbiol; 1987 Sep; 33(9):783-96. PubMed ID: 3690423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole.
    Morace G; Manzara S; Dettori G
    Chemotherapy; 1991; 37(1):23-31. PubMed ID: 2013239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reevaluation of the yeast killer phenomenon.
    Polonelli L; Morace G
    J Clin Microbiol; 1986 Nov; 24(5):866-9. PubMed ID: 3771773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Killer activity of yeasts isolated from natural environments against some medically important Candida species.
    Vadkertiová R; Sláviková E
    Pol J Microbiol; 2007; 56(1):39-43. PubMed ID: 17419188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility of yeasts for fluconazole and itraconazole. Evaluation of a microdilution test.
    Nenoff P; Oswald U; Haustein UF
    Mycoses; 1999; 42(11-12):629-39. PubMed ID: 10680439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Killer-sensitive relationships in yeasts from natural habitats.
    Stumm C; Hermans JM; Middelbeek EJ; Croes AF; de Vries GJ
    Antonie Van Leeuwenhoek; 1977; 43(2):125-8. PubMed ID: 596861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the killer toxin of several yeasts and the purification of a toxin of type K2.
    Pfeiffer P; Radler F
    Arch Microbiol; 1984 Apr; 137(4):357-61. PubMed ID: 6375620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaerobic yeast killer systems.
    Polonelli L; Menozzi MG; Campani L; Gerloni M; Conti S; Morace G; Chezzi C
    Eur J Epidemiol; 1992 May; 8(3):471-6. PubMed ID: 1397211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the sensitivity of the yeast-like fungi Candida and Torulopsis to yeast producers of killer toxins].
    Budak A; Laskownicka Z; Wiercioch E
    Med Dosw Mikrobiol; 1985; 37(3-4):210-4. PubMed ID: 3831631
    [No Abstract]   [Full Text] [Related]  

  • 20. Typing and patterns of cellular morphological alterations in Cryptococcus neoformans and Cryptococcus gattii isolates exposed to a panel of killer yeasts.
    Fuentefria AM; Faganello J; Pazzini F; Schrank A; Valente P; Vainstein M
    Med Mycol; 2007 Sep; 45(6):503-12. PubMed ID: 17710619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.